DM
Deerfield Management Portfolio holdings
AUM
$5.51B
1-Year Return
12.76%
This Quarter Return
-8.37%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.26B
AUM Growth
-$1.44B
(-21%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-22.76%
Top 10 Holdings %
Top 10 Hldgs %
53.77%
Holding
466
New
22
Increased
24
Reduced
24
Closed
360
Top Buys
| 1 |
NewAmsterdam Pharma
NAMS
|
+$87.7M |
| 2 |
Dynavax Technologies
DVAX
|
+$66M |
| 3 |
Oscar Health
OSCR
|
+$53.5M |
| 4 |
Legend Biotech
LEGN
|
+$50.5M |
| 5 |
Indivior
INDV
|
+$47.1M |
Top Sells
| 1 |
Nuvalent
NUVL
|
+$157M |
| 2 |
Kura Oncology
KURA
|
+$106M |
| 3 |
Catalyst Pharmaceutical
CPRX
|
+$64.6M |
| 4 |
Neurocrine Biosciences
NBIX
|
+$62.1M |
| 5 |
WAY
Waystar Holding Corp
WAY
|
+$60.8M |
Sector Composition
| 1 | Healthcare | 88.36% |
| 2 | Industrials | 0.23% |
| 3 | Consumer Staples | 0.01% |
| 4 | Energy | 0% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
iRadimed
IRMD
$914M
| – | – |
-7,137
| Closed | -$359K |
|
227
Jacobs Solutions
J
$17.3B
| – | – |
-1,778
| Closed | -$230K |
|
228
Johnson Controls International
JCI
$70.1B
| – | – |
-13,530
| Closed | -$1.05M |
|
229
St. Joe Company
JOE
$3.05B
| – | – |
-24,428
| Closed | -$1.42M |
|
230
KalVista Pharmaceuticals
KALV
$803M
| – | – |
-13,255
| Closed | -$153K |
|
231
KBR
KBR
$6.35B
| – | – |
-13,173
| Closed | -$858K |
|
232
KeyCorp
KEY
$21B
| – | – |
-10,252
| Closed | -$172K |
|
233
OrthoPediatrics
KIDS
$524M
| – | – |
-17,897
| Closed | -$485K |
|
|
NXDR
234
Nextdoor Holdings
NXDR
$778M
| – | – |
-20,586
| Closed | -$51.1K |
|
235
KLA
KLAC
$120B
| – | – |
-299
| Closed | -$232K |
|
236
Kulicke & Soffa
KLIC
$1.99B
| – | – |
-21,531
| Closed | -$972K |
|
237
Kimberly-Clark
KMB
$43.1B
| – | – |
-5,157
| Closed | -$734K |
|
238
Kinsale Capital Group
KNSL
$10.5B
| – | – |
-945
| Closed | -$440K |
|
239
Krystal Biotech
KRYS
$4.2B
| – | – |
-4,166
| Closed | -$758K |
|
240
Kohl's
KSS
$1.86B
| – | – |
-16,877
| Closed | -$356K |
|
|
241
Kura Oncology
KURA
$707M
| – | – |
-5,411,571
| Closed | -$106M |
|
242
Quaker Houghton
KWR
$2.5B
| – | – |
-4,935
| Closed | -$831K |
|
243
Leidos
LDOS
$22.9B
| – | – |
-1,814
| Closed | -$296K |
|
244
Lear
LEA
$6B
| – | – |
-11,067
| Closed | -$1.21M |
|
245
Lincoln Electric
LECO
$13.4B
| – | – |
-3,664
| Closed | -$704K |
|
246
LifeMD
LFMD
$292M
| – | – |
-241,329
| Closed | -$1.26M |
|
247
Lifestance Health
LFST
$2.18B
| – | – |
-64,787
| Closed | -$454K |
|
248
Lincoln National
LNC
$7.9B
| – | – |
-13,586
| Closed | -$428K |
|
249
Lowe's Companies
LOW
$153B
| – | – |
-5,913
| Closed | -$1.6M |
|
250
Stride
LRN
$7.17B
| – | – |
-5,746
| Closed | -$490K |
|